Activin and Inhibin

DDX3-IN-1 (Compound 16f) is a DEAD-box polypeptide 3 ( DDX3 ) inhibitor with CC 50 s of 50 and 36 μM for HIV and HCV , respectively. Antiviral activity.Form:Solid.

DDX3-IN-1 (Compound 16f) is a DEAD-box polypeptide 3 ( DDX3 ) inhibitor with CC 50 s of 50 and 36 μM for HIV and HCV , respectively. Antiviral activity.Form:Solid.

DDX3-IN-1 (Compound 16f) is a DEAD-box polypeptide 3 ( DDX3 ) inhibitor with CC 50 s of 50 and 36 μM for HIV and HCV , respectively. Antiviral activity.Form:Solid.

DDX3-IN-1 (Compound 16f) is a DEAD-box polypeptide 3 ( DDX3 ) inhibitor with CC 50 s of 50 and 36 μM for HIV and HCV , respectively. Antiviral activity.Form:Solid.

DDX3-IN-1 (Compound 16f) is a DEAD-box polypeptide 3 ( DDX3 ) inhibitor with CC 50 s of 50 and 36 μM for HIV and HCV , respectively. Antiviral activity.

DDX3-IN-2 is an active DEADbox polypeptide 3 ( DDX3 ) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistanceIn VitroDDX3-IN-2 behaves as a competitive

DDX3-IN-2 is an active DEADbox polypeptide 3 ( DDX3 ) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistanceIn VitroDDX3-IN-2 behaves as a competitive

DDX3-IN-2 is an active DEADbox polypeptide 3 ( DDX3 ) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistanceIn VitroDDX3-IN-2 behaves as a competitive

DDX3-IN-2 is an active DEADbox polypeptide 3 ( DDX3 ) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistanceIn VitroDDX3-IN-2 behaves as a competitive

DDX3-IN-2 is an active DEADbox polypeptide 3 ( DDX3 ) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistanceIn VitroDDX3-IN-2 behaves as a competitive

DDX3-IN-2 is an active DEADbox polypeptide 3 ( DDX3 ) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistanceIn VitroDDX3-IN-2 behaves as a competitive

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.